Literature DB >> 22684455

miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer.

Zhiwei Wang1, Wenyi Wei, Fazlul H Sarkar.   

Abstract

Jahid and colleagues have shown that miR-23a promotes the transition from indolent to invasive colorectal cancer through inhibition of the MTSS1 tumor suppressor. This study reveals a novel role of miR-23a in the acceleration of colorectal cancer progression.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22684455      PMCID： PMC3375870          DOI： 10.1158/2159-8290.CD-12-0177

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  11 in total

1.  miR-23a promotes the transition from indolent to invasive colorectal cancer.

Authors:  Sohail Jahid; Jian Sun; Robert A Edwards; Diana Dizon; Nicole C Panarelli; Jeffrey W Milsom; Shaheen S Sikandar; Zeynep H Gümüs; Steven M Lipkin
Journal:  Cancer Discov       Date:  2012-03-30       Impact factor: 39.397

Review 2.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

3.  [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].

Authors:  Hai-lin Tang; Min Deng; Qian-jin Liao; Xi Zeng; Xiu-tian Zhou; Qi Su
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2012-01

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.

Authors:  Q Wang; D-C Li; Z-F Li; C-X Liu; Y-M Xiao; B Zhang; X-D Li; J Zhao; L-P Chen; X-M Xing; S-F Tang; Y-C Lin; Y-D Lai; P Yang; J-L Zeng; Q Xiao; X-W Zeng; Z-N Lin; Z-X Zhuang; S-M Zhuang; W Chen
Journal:  Oncogene       Date:  2011-04-04       Impact factor: 9.867

6.  MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.

Authors:  Mikael Lerner; Josefin Lundgren; Shahab Akhoondi; Angelina Jahn; Hwee-Fang Ng; Farhad Akbari Moqadam; Joachim A F Oude Vrielink; Reuven Agami; Monique L Den Boer; Dan Grandér; Olle Sangfelt
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

Review 7.  Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.

Authors:  Ravindresh Chhabra; Richa Dubey; Neeru Saini
Journal:  Mol Cancer       Date:  2010-09-03       Impact factor: 27.401

8.  The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

Authors:  Susanne U Mertens-Talcott; Sudhakar Chintharlapalli; Xiangrong Li; Stephen Safe
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 9.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.

Authors:  Markus Welcker; Bruce E Clurman
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

10.  Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Maen Abdelrahim; Ala Abudayyeh; Indira Jutooru; Gayathri Chadalapaka; Fei Wu; Susanne Mertens-Talcott; Kathy Vanderlaag; Sung Dae Cho; Roger Smith; Stephen Safe
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396
View more
  19 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

2.  MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.

Authors:  Ru-Jin Zhuang; Xiao-Xu Bai; Wei Liu
Journal:  Cancer Biol Ther       Date:  2019-03-12       Impact factor: 4.742

3.  miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.

Authors:  Guangbin Wang; Bin Li; Yonghui Fu; Ming He; Jiashi Wang; Peng Shen; Lunhao Bai
Journal:  Tumour Biol       Date:  2015-01-27

4.  Clinical value of microRNA-23a upregulation in non-small cell lung cancer.

Authors:  Wei-Qing Qu; Lei Liu; Zhe Yu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Effects of MicroRNA-23a on Differentiation and Gene Expression Profiles in 3T3-L1 Adipocytes.

Authors:  Yong Huang; Jinxiu Huang; Renli Qi; Qi Wang; Yongjiang Wu; Jing Wang
Journal:  Genes (Basel)       Date:  2016-10-24       Impact factor: 4.096

6.  miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.

Authors:  Xue Liu; Jing Ru; Jian Zhang; Li-hua Zhu; Min Liu; Xin Li; Hua Tang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

7.  A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis.

Authors:  Yong Zhu; Dongsheng Wang; Fang Wang; Tingting Li; Lei Dong; Huiwen Liu; Yanni Ma; Fengbing Jiang; Haixin Yin; Wenting Yan; Min Luo; Zhong Tang; Guoyuan Zhang; Qiang Wang; Junwu Zhang; Jingguo Zhou; Jia Yu
Journal:  Nucleic Acids Res       Date:  2013-02-17       Impact factor: 16.971

8.  MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1.

Authors:  Lin Cheng; Tao Yang; Yongqin Kuang; Bin Kong; Sixun Yu; Haifeng Shu; Hutian Zhou; Jianwen Gu
Journal:  Oncol Lett       Date:  2014-01-14       Impact factor: 2.967

9.  MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma.

Authors:  Ning Wang; Meifen Zhu; Sai-Wah Tsao; Kwan Man; Zhangjin Zhang; Yibin Feng
Journal:  Mol Cancer       Date:  2013-10-08       Impact factor: 27.401

Review 10.  Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.

Authors:  Marta Passadouro; Henrique Faneca
Journal:  Int J Mol Sci       Date:  2016-05-13       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.